Jo Milner

4.2k citations

57 papers · 3.5k indexed · 1 hit paper · h-index 31

Impact in

Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
Oncology top 1%
- Cancer-related Molecular Pathways

Papers in ⓘ

Molecular Biology 39
- Epigenetics and DNA Methylation 6
- DNA Repair Mechanisms 6
- RNA modifications and cancer 6
- RNA Interference and Gene Delivery 6
Oncology 30
- Cancer-related Molecular Pathways 27

Co-authors: Ming Jiang (8 shared papers)Elizabeth Medcalf (2 shared papers)Jack R. Ford (4 shared papers)Andrei L. Okorokov (8 shared papers)Carlos P. Rubbi (7 shared papers)Simon J. Allison (7 shared papers)John R. P. Knight (4 shared papers)A Cook (3 shared papers)
Journals: Oncogene (11 papers)Virology (5 papers)Molecular and Cellular Biology (4 papers)Nature (3 papers)Current Opinion in Cell Biology (2 papers)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Jo Milner

57 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation 1991 · 528 citations

Peers

Countries citing papers authored by Jo Milner

Since Specialization

Citations

This map shows the geographic impact of Jo Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Milner more than expected).

Fields of papers citing papers by Jo Milner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Milner. The network helps show where Jo Milner may publish in the future.

Co-authors

The 25 scholars most cited alongside Jo Milner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jo Milner Line = papers co-authored together Jo Milner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation Cell ·Jo Milner, Elizabeth Medcalf Hit paper breakdown →	1991	528
2	Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference Oncogene ·Ming Jiang, Jo Milner	2002	301
3	Cancer-Specific Functions of SIRT1 Enable Human Epithelial Cancer Cell Growth and Survival Cancer Research ·Jack R. Ford, Ming Jiang, Jo Milner	2005	249
4	Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A Proceedings of the National Academy of Sciences ·Elena Bochkareva, Lilia Kaustov, Ayeda Ayed, Gwan‐Su Yi, Ying Lü, Antonio Pineda‐Lucena, Jack Liao, Andrei L. Okorokov, Jo Milner, C.H. Arrowsmith, Alexey Bochkarev	2005	230
5	SV40-53K antigen: A possible role for 53K in normal cells Virology ·Jo Milner, Su Milner	1981	166
6	Proteolysis by Calpains: a Possible Contribution to Degradation of p53 Molecular and Cellular Biology ·Magali Pariât, Serge Carillo, Marta Molinari, Catherine Salvat, Laurent Debüssche, Laurent Bracco, Jo Milner, Marc Piechaczyk	1997	138
7	Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells Genes & Development ·Ming Jiang, Jo Milner	2003	128
8	Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes Nature ·Jo Milner	1984	117
9	JNK2-dependent regulation of SIRT1 protein stability Cell Cycle ·Jack R. Ford, Shafiq U. Ahmed, Simon J. Allison, Ming Jiang, Jo Milner	2008	106
10	The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity The EMBO Journal ·Andrei L. Okorokov, Michael B. Sherman, Célia Plisson‐Chastang, Vera Grinkevich, Kristmundur Sigmundsson, Galina Selivanova, Jo Milner, Elena V. Orlova	2006	97
11	SIRT1, metabolism and cancer Current Opinion in Oncology ·John R. P. Knight, Jo Milner	2011	83
12	Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. PubMed ·Pierre Hainaut, Nicky Rolley, Michael J. Davies, Jo Milner	1995	76
13	Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus Oncogene ·Carlos P. Rubbi, Jo Milner	2000	68
14	Tumor Suppressor p53: Analysis of Wild-Type and Mutant p53 Complexes Molecular and Cellular Biology ·Jo Milner, Elizabeth Medcalf, A Cook	1991	67
15	The role of p53 in the normal control of cell proliferation Current Opinion in Cell Biology ·Jo Milner	1991	62
16	Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53 The EMBO Journal ·Andrei L. Okorokov, Frédérique Ponchel, Jo Milner	1997	56
17	DNA damage, p53 and anticancer therapies Nature Medicine ·Jo Milner	1995	56
18	The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage Oncogene ·Andrei L. Okorokov, Carlos P. Rubbi, Su Metcalfe, Jo Milner	2002	56
19	Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog Oncogene ·Nik Veldhoen, Jane C. Stewart, Robert Brown, Jo Milner	1998	55
20	Human Topoisomerase IIα and IIβ Interact with the C-Terminal Region of p53 Experimental Cell Research ·Ian G. Cowell, Andrei L. Okorokov, Sarah A. Cutts, Kay Padget, Margaret Bell, Jo Milner, Caroline A. Austin	2000	52

About Jo Milner

Jo Milner is a scholar working on Molecular Biology, Oncology, Genetics, Biotechnology and Geriatrics and Gerontology, having authored 57 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (27 papers), Cancer Research and Treatments (11 papers), Virus-based gene therapy research (11 papers), Sirtuins and Resveratrol in Medicine (8 papers), Epigenetics and DNA Methylation (6 papers), DNA Repair Mechanisms (6 papers), RNA modifications and cancer (6 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Geriatrics and Gerontology (418 citations), Oncology (1.7k citations), Biotechnology (461 citations), Molecular Biology (2.4k citations) and Cancer Research (494 citations). Jo Milner has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Ming Jiang, Elizabeth Medcalf, Jack R. Ford, Andrei L. Okorokov, Carlos P. Rubbi, Simon J. Allison, John R. P. Knight, A Cook, Shafiq U. Ahmed and Nik Veldhoen. Their work appears in journals such as Oncogene, Virology, Molecular and Cellular Biology, Nature and Current Opinion in Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact